Zacks Industry Outlook Medical Systems, American Well and Butterfly Network

Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.

Zacks Investment Research • Sep 14, 2026

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk

INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.

Zacks Investment Research • Sep 11, 2026

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

As of Sept. 10, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Sep 10, 2026

Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 2, 2026

Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.

GlobeNewsWire • Aug 26, 2026

INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?

Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.

Zacks Investment Research • Aug 21, 2026

Here's Why You Should Add INSP Stock to Your Portfolio Now

Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.

Zacks Investment Research • Aug 20, 2026

New Strong Buy Stocks for August 18th

ALGT, HMC, INSP, AII and ALL have been added to the Zacks Rank #1 (Strong Buy) List on August 18, 2026.

Zacks Investment Research • Aug 18, 2026

INSP's 28.1% Past-Month Rally Raises a Key Question for Investors

Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.

Zacks Investment Research • Aug 5, 2026

INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease

Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.

Zacks Investment Research • Aug 5, 2026